WKL Wolters Kluwer NV

Frost & Sullivan Radar Ranks Wolters Kluwer as a Top 20 AI Innovation Leader in Healthcare IT

, a leading global provider of trusted clinical technology and evidence-based solutions, is recognized by Frost & Sullivan as a . The independent analysis evaluated a field of more than 200 healthcare IT companies and ranked Wolters Kluwer among the top 20 for continuous innovation and growth focusing on areas where AI solutions are most relevant for hospitals, physicians and payers.

This press release features multimedia. View the full release here:

Wolters Kluwer AI Frost Radar (Graphic: Business Wire)

Wolters Kluwer AI Frost Radar (Graphic: Business Wire)

“In a market forecasted to reach more than $34 billion globally by 2025, Wolters Kluwer is one of the top growth performers in AI for healthcare IT and poised to move higher on the Radar,” commented Koustav Chatterjee, report author and analyst for Frost & Sullivan’s Global Transformational Health team. “In innovation metrics, Wolters Kluwer delivered remarkable results at scale for both payers and providers.”

Wolters Kluwer is coupling the expansive knowledge of its trusted clinical experts with impactful AI solutions that target complex problems in healthcare. According to the Frost report, the top-right Radar positioning of Wolters Kluwer, adjacent to well-recognized tech giants, highlights its superior deep learning and NLP capabilities, and showcases how Wolters Kluwer is reimagining predictive clinical surveillance.

A Global Powerhouse for AI in Healthcare

Frost & Sullivan forecasts Wolters Kluwer will expand its AI-enabled healthcare IT footprint, “working closely with large health systems, government agencies, and leading start-ups from Europe, the Middle East, and Southeast Asia in the next 2 to 3 years.” Frost sees growth from “healthcare stakeholders with the need and incentive to embrace full-fledged AI to improve clinical efficacy, augment financial performance, and streamline operational agility.”

“AI is deeply woven into the Wolters Kluwer DNA and it fully spans our Health solutions,” commented , Wolters Kluwer, Health. “The Frost Radar report validates years of effort and investment building a world-class AI ecosystem with a unique combination of data scientists, clinicians, and product teams that can make a meaningful impact on healthcare.”

Indicators of this AI innovation in Health solutions include:

  • Adaptive learning for next-generation doctors and nurses: Tomorrow’s clinicians get a strong start in medical and nursing education with adaptive learning powered by AI that optimizes student testing skills, remediation and performance in high-stakes USMLE or NCLEX exams with ® and ®.
  • Earlier intervention when it matters most: Minutes can be the difference between life and death for patients with hospital-acquired infections (HAIs) like sepsis or C.difficile. AI technology in ® and is so patients get every fighting chance.
  • Unlocking hidden insights: Critical patient information lost in physician notes is extracted and mapped by for better informed care and AI is eliminating .
  • Globalizing drug data: AI is being developed to dramatically accelerate and automate the mapping of highly variable drug data from countries around the world to to reduce medication errors, adverse drug events and unnecessary alerts.

Other rapid response innovations in clinical content and data science:

  • Wolters Kluwer leveraged from UpToDate® in a chat bot and developed Emmi Engage multimedia patient programs to help hospitals answer common questions about coronavirus. To help track the pandemic, a global interactive map

To learn more, download the Frost Radar report: .

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

For more information about our solutions, visit and follow us on and Twitter .

For more information, visit , follow us on , , , and .

EN
14/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details August 14 – August 20, 2025

Share Buyback Transaction Details August 14 – August 20, 2025 PRESS RELEASE                                         Share Buyback Transaction Details August 14 – August 20, 2025 Alphen aan den Rijn – August 21, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 89,500 of its own ordinary shares in the period from August 14, 2025, up to and including August 20, 2025, for €10.1 million and at an average share price of €112.94. These repurchases are part of the share buyback program annou...

Wolters Kluwers: 1 director

A director at Wolters Kluwers maiden bought 1,875 shares at 131.520USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

 PRESS RELEASE

Share Buyback Transaction Details August 7 – August 13, 2025

Share Buyback Transaction Details August 7 – August 13, 2025 PRESS RELEASE                                         Share Buyback Transaction Details August 7 – August 13, 2025 Alphen aan den Rijn – August 14, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 137,900 of its own ordinary shares in the period from August 7, 2025, up to and including August 13, 2025, for €16.2 million and at an average share price of €117.75. These repurchases are part of the share buyback program announc...

 PRESS RELEASE

Share Buyback Transaction Details July 31 – August 6, 2025

Share Buyback Transaction Details July 31 – August 6, 2025 PRESS RELEASE                                         Share Buyback Transaction Details July 31 – August 6, 2025 Alphen aan den Rijn – August 7, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 109,700 of its own ordinary shares in the period from July 31, 2025, up to and including August 6, 2025, for €14.5 million and at an average share price of €132.48. These repurchases are part of the share buyback program announced on...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

CTP: Good results, continuation of strong demand dynamics. KBC: 2025 outlook, strong uplift post 2Q. RELX, Wolters Kluwer: Thomson Reuters 2Q25 results. SBM Offshore: Guidance up, one-offs play a role. Xior Student Housing: On track, continued focus on pricing and pipeline

ResearchPool Subscriptions

Get the most out of your insights

Get in touch